Johnson & Johnson Aktie News

The recent jobs data showed that hiring in healthcare took a big jump in May, as the stock sector has stabilized a bit after years of underperformance.

We're at the end of earnings season. That means it's time for analysts to weigh in on the outlook for specific stocks.

These dividend stocks have solid underlying businesses. The cash flows should remain consistent regardless of the broader economic environment.

Holding dividend stocks remains one of the most effective long-term strategies, with companies that pay a regular dividend often being profitable and well-positioned for future growth, even during economic downturns.

These Dividend Aristocrats are rock-solid businesses with a steady cash flow. They've never disappointed me and can generate a reliable paycheck each quarter.

The summer months are here, but the markets are still faced with plenty of uncertainty, so we need to remain careful about which stocks we buy.

New long-term CARTITUDE-1 data show one-third of patients treated with CARVYKTI ®  remain progression-free CARTITUDE-4 analysis shows compelling overall survival and progression-free benefits in standard and high-risk subgroups across prior lines of treatment CHICAGO , June 3, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today new long-term follow-up data from the Phase 1b/2 CART...

More than half of patients maintained minimal residual disease (MRD) negativity (10-5) with DARZALEX FASPRO ®  for 24 months or longer in the Phase 3 PERSEUS study Data from Phase 3 CEPHEUS study show 60 percent overall MRD negativity (10−5) and improved PFS with DARZALEX FASPRO ® in transplant-ineligible newly diagnosed patients CHICAGO , June 3, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: J...